
March 1, 2023
Quantifind Raises $23M and Signs Four of the World’s Largest Banks that will use Quantifind’s AI Platform Graphyte™ to Accurately and Cost Efficiently Identify and Combat Financial Crime Risks
Quantifind Raises $23M and Signs Four of the World's Largest Banks that will use Quantifind's AI Platform Graphyte™ to Accurately and Cost Efficiently Identify and Combat Financial Crime Risks

October 28, 2021
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients

July 1, 2021
Hewlett Packard Enterprise Expands HPE GreenLake Edge-to-Cloud Platform with Acquisition of Zerto, a Leader in Cloud Data Management and Protection
Hewlett Packard Enterprise Expands HPE GreenLake Edge-to-Cloud Platform with Acquisition of Zerto, a Leader in Cloud Data Management and Protection

June 1, 2021
Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy
Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy

May 28, 2021
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies

February 2, 2021
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries

July 28, 2020
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

July 21, 2020
TRIMEDX Announces Partnership With Medigate to Provide Real-Time Visibility Into Connected Medical Devices, Launches Expanded Offerings for Health Systems
TRIMEDX Announces Partnership With Medigate to Provide Real-Time Visibility Into Connected Medical Devices, Launches Expanded Offerings for Health Systems

October 16, 2018
eFFECTOR Therapeutics Announces Clinical Collaboration with Merck to Conduct a Phase 2 Combination Trial to Evaluate eFFECTOR’s Tomivosertib with KEYTRUDA for Metastatic Triple Negative Breast Cancer
eFFECTOR Therapeutics Announces Clinical Collaboration with Merck to Conduct a Phase 2 Combination Trial to Evaluate eFFECTOR's Tomivosertib with KEYTRUDA for Metastatic Triple Negative Breast Cancer

September 25, 2018
Luma Health Expands Patient Relationship Management Platform to Improve Collaboration, Deliver Care in More Timely Manner and Ultimately Drive Better Health Outcomes
Luma Health Expands Patient Relationship Management Platform to Improve Collaboration, Deliver Care in More Timely Manner and Ultimately Drive Better Health Outcomes

May 22, 2018
Zerto Disrupts Backup and Data Protection Market with Industry’s First Converged IT Resilience Platform to Solve Digital Transformation Challenges
Zerto Disrupts Backup and Data Protection Market with Industry’s First Converged IT Resilience Platform to Solve Digital Transformation Challenges

September 20, 2017
Inspire Medical Systems’ Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
Inspire Medical Systems' Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment

June 28, 2017
Zerto Wins Ransomware Protection Company of the Year at the 2017 Storage Awards
2017 has already seen a number of high-profile ransomware attacks. The most widely disruptive variant so far, WannaCry, infected over 300,000 computers in more than 150 countries within just a few days during May.

June 12, 2017
HeartFlow Announces Its Novel, Non-Invasive FFRct Technology for Coronary Artery Disease Receives Positive Review from Blue Cross Blue Shield
HeartFlow, Inc. today announced that Blue Cross Blue Shield (BCBS) Association’s Evidence Street has issued a positive healthcare evidence review…

May 24, 2017
Zerto Previews New Public Cloud Technology at ZertoCON 2017 with Bi-Directional Enterprise Application Replication and Recovery
Zerto, an award-winning provider of enterprise IT resilience cloud solutions, today announced it will preview new technology for enterprise-class application replication…

February 13, 2017
Wellington Financial Provides US$6M to Electric Cloud to Accelerate Growth of its Market Leading DevOps Release Automation Platform
Wellington Financial LP, a privately-held specialty finance firm, today announced it has invested US$6 million in financing to support the growth of Electric Cloud…

October 11, 2016
PLUMgrid to Showcase Secure SDN for Containers and OpenStack Clouds at OpenStack Summit Barcelona
SANTA CLARA, CA – PLUMgrid, a leader of secure and scalable SDN and NFV solutions for containers and OpenStack® clouds, will exhibit and present at the OpenStack Summit in Barcelona, October 25-28.

March 1, 2023
Quantifind Raises $23M and Signs Four of the World’s Largest Banks that will use Quantifind’s AI Platform Graphyte™ to Accurately and Cost Efficiently Identify and Combat Financial Crime Risks
Quantifind Raises $23M and Signs Four of the World's Largest Banks that will use Quantifind's AI Platform Graphyte™ to Accurately and Cost Efficiently Identify and Combat Financial Crime Risks

October 28, 2021
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients

July 1, 2021
Hewlett Packard Enterprise Expands HPE GreenLake Edge-to-Cloud Platform with Acquisition of Zerto, a Leader in Cloud Data Management and Protection
Hewlett Packard Enterprise Expands HPE GreenLake Edge-to-Cloud Platform with Acquisition of Zerto, a Leader in Cloud Data Management and Protection

June 1, 2021
Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy
Standard Bariatrics Secures $35M in Series B Funding to Accelerate Development and Commercialization of Their First Bariatric Surgical Platform for Sleeve Gastrectomy

May 28, 2021
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies

February 2, 2021
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries
Ribon Therapeutics Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop and Commercialize RBN-2397 In Japan, South Korea, Taiwan and ASEAN Countries

July 28, 2020
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Cleave Therapeutics Announces Commencement of a Phase 1 Clinical Study of CB-5339, A Valosin-Containing Protein (VCP)/p97 Inhibitor, in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

July 21, 2020
TRIMEDX Announces Partnership With Medigate to Provide Real-Time Visibility Into Connected Medical Devices, Launches Expanded Offerings for Health Systems
TRIMEDX Announces Partnership With Medigate to Provide Real-Time Visibility Into Connected Medical Devices, Launches Expanded Offerings for Health Systems

October 16, 2018
eFFECTOR Therapeutics Announces Clinical Collaboration with Merck to Conduct a Phase 2 Combination Trial to Evaluate eFFECTOR’s Tomivosertib with KEYTRUDA for Metastatic Triple Negative Breast Cancer
eFFECTOR Therapeutics Announces Clinical Collaboration with Merck to Conduct a Phase 2 Combination Trial to Evaluate eFFECTOR's Tomivosertib with KEYTRUDA for Metastatic Triple Negative Breast Cancer

September 25, 2018
Luma Health Expands Patient Relationship Management Platform to Improve Collaboration, Deliver Care in More Timely Manner and Ultimately Drive Better Health Outcomes
Luma Health Expands Patient Relationship Management Platform to Improve Collaboration, Deliver Care in More Timely Manner and Ultimately Drive Better Health Outcomes

May 22, 2018
Zerto Disrupts Backup and Data Protection Market with Industry’s First Converged IT Resilience Platform to Solve Digital Transformation Challenges
Zerto Disrupts Backup and Data Protection Market with Industry’s First Converged IT Resilience Platform to Solve Digital Transformation Challenges

September 20, 2017
Inspire Medical Systems’ Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
Inspire Medical Systems' Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment

June 28, 2017
Zerto Wins Ransomware Protection Company of the Year at the 2017 Storage Awards
2017 has already seen a number of high-profile ransomware attacks. The most widely disruptive variant so far, WannaCry, infected over 300,000 computers in more than 150 countries within just a few days during May.

June 12, 2017
HeartFlow Announces Its Novel, Non-Invasive FFRct Technology for Coronary Artery Disease Receives Positive Review from Blue Cross Blue Shield
HeartFlow, Inc. today announced that Blue Cross Blue Shield (BCBS) Association’s Evidence Street has issued a positive healthcare evidence review…

May 24, 2017
Zerto Previews New Public Cloud Technology at ZertoCON 2017 with Bi-Directional Enterprise Application Replication and Recovery
Zerto, an award-winning provider of enterprise IT resilience cloud solutions, today announced it will preview new technology for enterprise-class application replication…

February 13, 2017
Wellington Financial Provides US$6M to Electric Cloud to Accelerate Growth of its Market Leading DevOps Release Automation Platform
Wellington Financial LP, a privately-held specialty finance firm, today announced it has invested US$6 million in financing to support the growth of Electric Cloud…

October 11, 2016
PLUMgrid to Showcase Secure SDN for Containers and OpenStack Clouds at OpenStack Summit Barcelona
SANTA CLARA, CA – PLUMgrid, a leader of secure and scalable SDN and NFV solutions for containers and OpenStack® clouds, will exhibit and present at the OpenStack Summit in Barcelona, October 25-28.














































































































